Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| 1 |
Alibaba
BABA
|
+$812M |
| 2 |
AGN
Allergan plc
AGN
|
+$479M |
| 3 |
TWTR
Twitter, Inc.
TWTR
|
+$344M |
| 4 |
Apple
AAPL
|
+$312M |
| 5 |
Meta Platforms (Facebook)
META
|
+$264M |
Top Sells
| 1 |
RTX Corp
RTX
|
+$839M |
| 2 |
Qualcomm
QCOM
|
+$393M |
| 3 |
Las Vegas Sands
LVS
|
+$367M |
| 4 |
DISCA
Discovery, Inc. Series A Common Stock
DISCA
|
+$363M |
| 5 |
Perrigo
PRGO
|
+$359M |
Sector Composition
| 1 | Healthcare | 18.63% |
| 2 | Consumer Discretionary | 14.4% |
| 3 | Communication Services | 12.93% |
| 4 | Technology | 11.61% |
| 5 | Energy | 10.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLXN
451
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $15.7M | 0.01% |
860,834
+40,157
| +5% | +$733K |
|
452
IMAX
IMAX
$1.67B
| $15.4M | 0.01% |
560,517
+18,808
| +3% | +$516K |
|
453
Monolithic Power Systems
MPWR
$41B
| $15.4M | 0.01% |
+348,883
| New | +$15.4M |
|
454
Marcus & Millichap
MMI
$1.26B
| $15.3M | 0.01% |
504,872
+37,099
| +8% | +$1.12M |
|
|
CMRX
455
DELISTED
Chimerix, Inc.
CMRX
| $15.3M | 0.01% |
553,129
-63,693
| -10% | -$1.76M |
|
456
Tempest Therapeutics
TPST
$46.7M
| $14.8M | 0.01% |
305
+80
| +36% | +$3.88M |
|
457
Agios Pharmaceuticals
AGIO
$2.07B
| $14.6M | 0.01% |
237,425
+186
| +0.1% | +$11.4K |
|
|
TFM
458
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $14.5M | 0.01% |
415,171
-286
| -0.1% | -$9.99K |
|
|
AVNR
459
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $14.3M | 0.01% |
+1,200,000
| New | +$14.3M |
|
|
DATA
460
DELISTED
Tableau Software, Inc.
DATA
| $14.3M | 0.01% |
196,196
-19,755
| -9% | -$1.44M |
|
|
ACOR
461
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $14.2M | 0.01% |
3,499
+3
| +0.1% | +$12.2K |
|
|
FEIC
462
DELISTED
FEI COMPANY
FEIC
| $13.1M | 0.01% |
173,516
-201
| -0.1% | -$15.2K |
|
|
TTPH
463
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $12.9M | 0.01% |
32,406
+49
| +0.2% | +$19.6K |
|
|
MLU
464
DELISTED
METLIFE, INC. COM EQUITY UNIT
MLU
| $12.7M | 0.01% |
413,000
| – | – |
|
465
McEwen Inc.
MUX
$742M
| $12.3M | 0.01% |
625,133
-9,418
| -1% | -$185K |
|
466
Douglas Emmett
DEI
$2.75B
| $12.2M | 0.01% |
475,430
-15,620
| -3% | -$401K |
|
|
PSXP
467
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $11.5M | 0.01% |
172,992
-27,983
| -14% | -$1.87M |
|
468
Asbury Automotive
ABG
$4.86B
| $11.5M | 0.01% |
178,830
+6,103
| +4% | +$393K |
|
469
Madrigal Pharmaceuticals
MDGL
$9.59B
| $11.1M | 0.01% |
104,968
+113
| +0.1% | +$11.9K |
|
470
United Natural Foods
UNFI
$1.72B
| $11M | 0.01% |
178,669
-257,012
| -59% | -$15.8M |
|
471
ProQR Therapeutics
PRQR
$237M
| $10.8M | 0.01% |
+630,370
| New | +$10.8M |
|
|
ZU
472
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
| $10.8M | 0.01% |
284,934
-72,206
| -20% | -$2.74M |
|
|
TUES
473
DELISTED
Tuesday Morning Corp
TUES
| $10.7M | 0.01% |
+550,134
| New | +$10.7M |
|
474
MPLX
MPLX
$50.8B
| $10.6M | 0.01% |
180,342
-13,493
| -7% | -$795K |
|
475
Insmed
INSM
$30.8B
| $10.4M | 0.01% |
+800,438
| New | +$10.4M |
|